These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15647195)

  • 21. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
    Staub DR; Evans AK; Lowry CA
    Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of central urocortin on carbon tetrachloride-induced acute liver injury in rats.
    Yokohama S; Yoneda M; Watanobe H; Kono T; Nakamura K; Makino I; Terano A
    Neurosci Lett; 2001 Nov; 313(3):149-52. PubMed ID: 11682149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators.
    Wiley KE; Davenport AP
    Br J Pharmacol; 2004 Oct; 143(4):508-14. PubMed ID: 15381637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
    Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
    Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
    Yin Y; Dong L; Yin D
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e79-87. PubMed ID: 17944898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
    Miguel TT; Nunes-de-Souza RL
    Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticotropin releasing factor receptor 1 (CRF1) and CRF2 agonists exert an anti-inflammatory effect during the early phase of inflammation suppressing LPS-induced TNF-alpha release from macrophages via induction of COX-2 and PGE2.
    Tsatsanis C; Androulidaki A; Dermitzaki E; Gravanis A; Margioris AN
    J Cell Physiol; 2007 Mar; 210(3):774-83. PubMed ID: 17117478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corticotropin-releasing factor receptor type 1, but not type 2, in the ventromedial hypothalamus modulates dopamine release in female rats.
    Muramatsu T; Inoue K; Iwasaki S; Yamauchi T; Hayashi T; Kiriike N
    Pharmacol Biochem Behav; 2006 Oct; 85(2):435-40. PubMed ID: 17109941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of a selective agonist and antagonist of CRF2 receptors on cardiovascular function in the rat.
    Mackay KB; Stiefel TH; Ling N; Foster AC
    Eur J Pharmacol; 2003 May; 469(1-3):111-5. PubMed ID: 12782192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lafutidine increases hepatic blood flow via potentiating the action of central thyrotropin-releasing hormone in rats.
    Yoneda M; Kurosawa M; Watanobe H; Terano A
    J Gastroenterol Hepatol; 2003 Feb; 18(2):177-84. PubMed ID: 12542603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Central Corticotropin-Releasing Factor on Hepatic Lipid Metabolism and Inflammation-Related Gene Expression in Rats.
    Nakade Y; Kitano R; Yamauchi T; Kimoto S; Sakamoto K; Inoue T; Kobayashi Y; Ohashi T; Sumida Y; Ito K; Yoneda M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divergent role for CRF1 and CRF2 receptors in the modulation of visceral pain.
    Nijsen M; Ongenae N; Meulemans A; Coulie B
    Neurogastroenterol Motil; 2005 Jun; 17(3):423-32. PubMed ID: 15916630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intracisternal thyrotropin-releasing hormone on hepatic blood flow in rats.
    Tamori K; Yoneda M; Nakamura K; Makino I
    Am J Physiol; 1998 Feb; 274(2):G277-82. PubMed ID: 9486180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of CRF and the urocortins on [3H]GABA release from the rat amygdala--an in vitro superfusion study.
    Bagosi Z; Jászberényi M; Szabó G; Telegdy G
    Brain Res Bull; 2008 Jan; 75(1):15-7. PubMed ID: 18158090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous urocortin II decreases blood pressure through CRF(2) receptor in rats.
    Chen CY; Doong ML; Rivier JE; Taché Y
    Regul Pept; 2003 May; 113(1-3):125-30. PubMed ID: 12686471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central CRF inhibits gastric emptying of a nutrient solid meal in rats: the role of CRF2 receptors.
    Martinez V; Barquist E; Rivier J; Taché Y
    Am J Physiol; 1998 May; 274(5):G965-70. PubMed ID: 9612279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats.
    Zhao Y; Valdez GR; Fekete EM; Rivier JE; Vale WW; Rice KC; Weiss F; Zorrilla EP
    J Pharmacol Exp Ther; 2007 Dec; 323(3):846-54. PubMed ID: 17855476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
    Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
    Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation.
    Valdez GR; Sabino V; Koob GF
    Alcohol Clin Exp Res; 2004 Jun; 28(6):865-72. PubMed ID: 15201629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats.
    Nakade Y; Fukuda H; Iwa M; Tsukamoto K; Yanagi H; Yamamura T; Mantyh C; Pappas TN; Takahashi T
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1037-44. PubMed ID: 17158256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.